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The amplitude and phase of the second harmonic (15 Hz) of the electroretinographic responses to three 
different spatial frequency grating stimuli (0.25, 1 and 4 c/deg), reversed at 7.5 Hz, were studied in 
normal human subjects, before and 30 min after the systemic administration of three doses (0.071, 
0.357 or 1.428 mg/kg) of a selective D2 blocker, l-suipiride, to three populations of 18, 19 or 20 
subjects. The effect of the drug on the pattern electroretinogram (PERG) was clearly dose-dependent, 
being greatest on the responses to 4 c/deg. The mean decrease in second harmonic amplitude was 
--13.8% after 0.071mg/kg of l-sulpiride, --23.5% after 0.357mg/kg and -28.5% after 
1.428 mg/kg. The last two variations were significant at P < 0.01 and P < 0.01 respectively. These 
data suggest hat a dose-dependent effect on the human retinal response to 4 c/deg stimuli exists, 
probably mediated by a coupling between l-sulpiride and D2 receptors. Lastly, our data suggest hat 
D2 receptors may play an important role in the pathophysiology of visual dysfunction in Parkinson's 
disease, that has been described to be more significant at medium spatial frequency (2-5 c/deg). 
Dopamine Human Electroretinogram l-Sulpiride Parkinson's disease 
INTRODUCTION 
Dopaminergic ells have been described in the human 
retina (Borbe, Fehske, Muller, Nover & Wollert, 1982; 
Dearry, Falardeu, Shores & Caron, 1991; Denis, Elena, 
Nordmann, Saraux & Lapalus, 1990; Ehinger, 1982; 
Ehinger, 1983; Ehinger & Dowling, 1987; Frederick, 
Rayborn, Laties, Lam & Hollyfield, 1982; Zarbin, 
Wamsley, Palacios & Kuhar, 1986) and the presence of 
both of the two main receptor subtypes D1 and D2 has 
been reported (McGonigle, Wax & Molinoff, 1988; 
Schorderet & Nowak, 1990). The electrophysiological 
effects of their selective activation or inactivation have 
been described in animals (Jensen, 1989, 1992; Jensen 
& Daw, 1986; Ikeda, Robbins & Wakakuwa, 1987; 
Piccolino, Witkovsky & Trimarchi, 1987; Schneider & 
Zrenner, 1991; Witkovsky, Stone & Tranchina, 1989). In 
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human subjects, at relatively high doses, l-sulpiride, a 
selective D2 blocker, has been reported to reduce the 
amplitude of the retinal responses to steady-state grating 
reversal stimulation of coarse spatial frequencies (SFs) 
(Stanzione, Traversa, Pierantozzi, Semprini, Marciani & 
Bernardi, 1992). A spatial frequency tuning alteration by 
l-sulpiride has also been reported recently in monkey 
(Tagliati, Bodis-Wollner, Kovanecz & Stanzione, 1994). 
However, there is a lack of data about a dose-dependent 
effect of l-sulpiride, which could indicate specific coup- 
ling between antagonist and receptor, giving rise to a 
typical dose-response curve reaching the saturation level 
with an hyperbolic or sigrnoid shape. In order to inves- 
tigate the specificity of l-sulpiride action on the retinal 
D2 receptors in humans, we studied the effects of three 
different doses (0.071, 0.357 and 1.428mg/kg, corre- 
sponding to 5, 25 and 100 mg of drug in a 70 kg subject) 
of the drug on the human PERG. The safety of human 
volunteers was considered when choosing the doses. 
Moreover, at each given dose we tested three different 
stimulus SFs in order to verify whether adose-dependent 
effect is present only for a specific dimension of the visual 
stimulus. This could help to clarify the role of D2 
receptors in the retinal dysfunction described in Parkin- 
son's disease (PD) (for a review see Bodis-WoUner, 1990) 
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which has been described as a selective impairment of 
visual processing at medium SF (Bodis-Wollner, Marx, 
Mitra, Bobak, Mylin & Yahr, 1987). Selective DI recep- 
tor antagonists are not currently available in clinical use, 
preventing the possibility to compare data concerning a 
possible complementary action of the two receptorial 
systems. 
SUBJECTS AND METHODS 
Seventy-six young, healthy volunteers [35 males and 
41 females, mean age 28 yr _+ 5 yr (SD)] were involved in 
this study. They were colleagues, residents or personnel 
from the Neurological Clinic of our University. All 
participants were informed of the aim of the research 
and gave their informed consent. All had normal (20/25) 
or corrected-to-normal visual acuity. PERGs were 
recorded in one eye from each subject, sequentially 
stimulated by all three types of stimuli, before and 
30 min (Reina, Sacchi & Aguggini, 1979) after a single 
dose of 0.071, 0.357 or 1.428 mg/kg of l-sulpiride i.m. 
(kindly supplied by Ravizza, Italy) or placebo. Nineteen 
subjects were treated with 0.071 mg/kg, 20 subjects with 
0.357 mg/kg and 18 subjects with 1.428 mg/kg. Nineteen 
subjects were treated with placebo in order to obtain a 
reference group. 
We studied the effects of increasing doses of l-sulpiride 
and placebo on the retinal responses evoked by low 
(0.25 c/deg, 11 °55' of visual angle, TV screen positioned 
at distance l l5cm), coarse (1 c/deg, 11"55' of visual 
angle, TV screen positioned at distance 115 cm) and 
medium (4 c/deg, 542'  of visual angle, TV screen posi- 
tioned at distance 240cm) SF square grating stimuli 
modulated at 7.5 Hz. PERGs were recorded by means 
of model 12A5 Grass amplifiers, amplified 50.000×, 
band-pass filtered at 1-100 Hz. Each recording was the 
average of 500 single trials of 500 msec, after having 
rejected any single trials contaminated by artifacts by 
means of an automatic window system (50/~V). Further 
details of the recording techniques have been published 
(Stanzione t al., 1992). Fast Fourier transforms (FFT), 
by means of zero-padding (so that the frequency 
resolution was 1 Hz), were performed, and the power 
and phase of the second harmonic (15 Hz) taken into 
account. At least two recordings were performed for 
each SF. A phase stability (< 30 deg of phase difference) 
and a power of 15Hz double that at the adjacent 
harmonics (14 and 16 Hz) were considered to be signs of 
reliable potentials. The better ecording was used in the 
statistical analysis. 
All the data were analysed by means of a two-way 
ANOVA for each dose, utilizing the SFs (0.25, I and 
4 c/deg) and drug administration (control and drug) as 
within factors. Moreover, an analysis for each SF was 
performed by means of a two-way ANOVA utilizing 
drug administration (control and drug) and drug doses 
(0.071, 0.357 and 1.429mg/kg) as within factors. 
Planned comparisons were performed in order to evalu- 
ate the significance of single differences between the 
retinal responses before and after/-sulpiride at different 
SFs. Student's t-test for paired samples, corrected with 
Bonferroni correction for multiple comparisons, was 
also performed in order to have a control test. Phase 
variations were analysed by means of Hotelling's t-test 
corrected for multiple comparisons (Zar, 1974). 
RESULTS 
Nineteen subjects were recorded with the procedure 
described in the Methods, utilizing placebo injection to 
ensure stability of the recording method. The mean 
amplitude at 0.25 c/deg in the control recording was 
0.822 _+ 0.225 #V and the mean phase was 248 + 23 deg; 
at l c/deg the mean amplitude was 0.795 +_0.274~V 
and mean phase was 225 + 26deg; at 4c/deg the 
mean amplitude was 0.358 _+ 0.275 #V and mean phase 
was 203 _+ 37 deg. After placebo the mean amplitude 
and phase were 0.781 +0.232~tV and 244 + 23deg 
at 0.25 c/deg; 0.826 + 0.304 ~tV and 229 + 22 deg at 
1 c/deg; 0.346 _+ 0.304/iV and 203 _+ 29 deg at 4 c/deg. 
None of the differences between control values and 
placebo administration were statistically significant by 
either the ANOVA analysis or Bonferroni-corrected 
Student's t-test. Only a significance of the main effect 
"SFs" in the ANOVA analysis was observed. Because of 
the smaller stimulated retinal area, PERG responses to 
4 c/deg stimulation were smaller (Hess & Backer, 1984), 
giving rise to a significance for the SF factor in the 
ANOVA analysis (d.f. 1/36, F =45.6, P < 0.0001). 
The PERG data obtained from the subjects included 
in the study with l-sulpiride will be presented according 
to the administered dose of/-sulpiride (0.071, 0.357 or 
1.428 mg/kg). Table 1 and Fig. 2 present a synoptic view 
of the overall results. Figure I presents FFT examples 
before and after the three doses of/-sulpiride in three 
different representative subjects. 
O. 071 mg /kg 
At the lowest dose used in this study /-sulpiride did 
not produce statistically significant variations of PERG 
responses, analysed with either Student's t-test or 
ANOVA (see Table 1, 0.071 mg/kg row). 
Because of the smaller stimulated retinal area, PERG 
responses to 4 c/deg stimulation were smaller (Hess & 
Backer, 1984), giving rise to a significance for the SF 
factor in the ANOVA analysis (d.f. 1/18, F= 21.3, 
P < 0.0001). 
0.357mg/kg 
The dose of 0.357mg/kg induced a mean PERG 
amplitude variation very close to that producing a 
signifi~:ance for the factor "drug administration" in the 
ANOVA analysis (d.f. 1/19, F = 3.47, P = < 0.08) (see 
Table 1, 0.357 mg/kg row). The planned comparison 
showed a highly significant amplitude decrease of the 
PERG response licited by 4c/deg (d.f. 1/19, F= 8.4, 
P < 0.01) with the mean amplitude decreasing from 
0.386 + 0.219/~V, to 0.295 + 0.217 ~tV, yielding a mean 
decrement of 23.5%. This decrement also was evident 
when analysed by the Student's t-test for paired samples 
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TABLE 1. Summary of the mean values of amplitude (/~V) and phase (deg) of the second harmonic of PERG responses to the three different 
SFs: 0.25 c/deg (left), 1 c/deg (middle) and 4 c/deg (right), before and after drugs administration 
0.25 c/deg n.s. 1 c/deg P < 0.05 4 c/deg P < 0.01 
Amplitude Phase Amplitude Phase Amplitude 
mean ___ SD Delta mean + SD mean _ SD Delta mean __+ SD mean _+ SD Delta 
(/~V) (%) (deg) (#V) (%) (deg) (#V) (%) 
Phase 
mean + SD 
(deg) 
Control 0.822 + 0.22 248 _ 23 0.795 + 0.27 225 + 26 0.358 + 0.27 
Placebo 0.781 + 0.23 - 4.98% 244 + 23 0.826 ___ 0.30 + 3.89% 229 _.+ 22 0.346 _ 0.30 - 3.35% 
n.s. (n = 19) n.s. n.s. n.s. 
n.s. n.s. n.s. 
Control 0.843 + 0.36 244 _+ 34 0.640 + 0.20 206 + 39 0.296 __+ 0.13 
l-Sulpiride 0.901 + 0.63 + 6.88% 253 + 36 0.547 _ 0.22 - 14.5% 204 + 37 0.255 _+ 0.14 - 13.8% 
0.071 mg/kg n.s. n.s. n.s. 
n.s. (n = 19) n.s. n.s. n.s. 
Control 0.902 __+ 0.43 237 + 18 0.826 + 0.36 208 + 40 0.386 ___ 0.21 
I-Sulpiride 0.824 + 0.33 - 8.42% 235 + 16 0.827 + 0.30 + 0.12% 208 + 32 0.295 + 0.21 - 23.5% 
0.357 mg/kg n.s. n.s. P < 0.01 
P = 0.07 (n = 20) n.s. n.s. P < 0.05 
Control 0.533 _ 0.16 221 ___ 27 0.489 + 0.23 208 + 23 0.245 + 0.10 
l-Sulpiride 0.497 ___ 0.15 - 6.75% 227 + 34 0.340 + 0.16 - 30.4% 180 + 46 0.175 + 0.08 - 28.5% 
1.428 mg/kg n.s. P < 0.05 P < 0.01 
P < 0.01 (n = 18) n.s. P < 0.05 P < 0.05 
203 + 37 
203 + 29 
189 __+ 56 
195 ___ 81 
201 + 78 
210 + 62 
195 + 44 
184 + 73 
The n.s. following 0.25 c/deg and the significance following 1 c/deg and 4 c/deg in the upper part, are the results of the ANOVA analysis for 
the factor "drug administration" performed one-way with all the three doses of l-sulpiride for each SF separately. In the upper part the 
results related to placebo administration are reported. Below the results related to the doses of 0.071, 0.375 and 1.428 mg/kg are reported. 
The significance reported under each dose is obtained by ANOVA one-way with the three SFs for that dose only. The significance reported 
under each couple of values (before and after drug administration) are obtained by planned comparison i the ANOVA (A) and by Bonferroni 
test (B) between mean values before and after drug administration. 
(n = 20, t = 2.89, P < 0.01), corrected with Bonferroni 
(P < 0.05). The responses produced by the two other 
SFs did not change in a statistically significant way. The 
main effect of "SF" also was significant. None of the 
phase changes were statistically significant (see Table 1). 
1.428mg/kg 
l-Sulpiride at 1.428 mg/kg produced more significant 
effects than those found with the lower doses (see 
Table 1, 1.428mg/kg row). The PERG response to 
4 c/deg stimulation showed a mean amplitude decrease 
from 0.245 __ 0.102 /~V to 0.175_0.087~tV, with a 
mean percentage decrement of amplitude of -28.5%.  
The response to 1 c/deg also showed a decrease of the 
PERG mean amplitude from 0.489__+0.231/tV, to 
0.340_0.160#V; the mean percentage decrement of 
amplitude was -30 .4%.  The PERG produced by 
0.25 c/deg stimulation decreased from 0.533 ___ 0.169 #V 
to 0.497 _ 0.154/~V, with a main decrement of -6.75%0. 
ANOVA analysis showed that the main effect of the 
factor "drug application" was significant at the level of 
P < 0.01 (d.f. 1/17, F = 7.54). The planned comparisons 
showed no significant change of PERG response to 
0.25c/deg stimulation (d.f. 1/17, F=0.9 ,  P =n.s.), 
while the reductions of the responses to 1 and 4 c/deg 
were significant (d.f. 1/17, F = 6.24, P < 0.05 at 1 c/deg 
and d.f. 1/17, F= 12.3, P <0.01 at 4c/deg). Student's 
t-test for paired samples also showed a significant 
change of the response to 1 c/deg stimulation (n = 18, 
t = 2.49, P < 0.05) confirmed by Bonferroni correction 
(P<0.05) .  The same was observed for 4c/deg 
stimulation (Student's t-test, n = 18, t = 3.51, P < 0.01; 
Bonferroni P < 0.05). The main effect "SF" was also 
significant according to that reported above. None of 
the phase changes were statistically significant (see 
Table 1). 
The two-way ANOVA analysis with "drug doses" 
(0.071, 0.357 and 1.428 mg/kg) as between factor and 
"drug administration" (control and drug) as within 
factor performed separately at each "SF", showed a 
significant decrease at l c/deg (d.f. 1/54, F=5.83 ,  
P < 0.05) and at 4 c/deg (d.f. 1/54, F = 20.14, P < 0.01). 
The drug administration effect was not significant at 
0.025 c/deg. The significance levels are reported in the 
upper part of Table 1. 
DISCUSSION 
The most important finding of this study is that 
l-sulpiride decreases the PERG responses to medium SF 
stimuli in a dose-dependent manner. Control data of the 
placebo group ensure the stability of these recordings 
and drug-related nature of the observed significant vari- 
ations after l-sulpiride. The PERG evoked by 4 c/deg 
stimulus was the response most consistently affected by 
the different doses of l-sulpiride: - 13.8%, - 23.5% and 
-28 .5% following administration of increasing doses. 
In order to verify whether these results depend on the 
specific coupling between the dopaminergic antagonist 
and the receptor, we tested our data with a theoretical 
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FIGURE I. FFT traces from three different subjects before and after the administration of the reported three doses of 
l-sulpiride (left part). In each subject the retinal response to 0.25, 1 and 4 c/deg were recorded (columns). Each frame shows 
the response analysed by means of FFT. The computer is auto-scaling and the peak power is reported in the top-left of each 
frame. 
dose response curve. Assuming that the effect of a 
dose lower than 0.071 mg/kg (e.g. 0.010mg/kg) can 
be considered null, our experimental PERG variations 
at 4c/deg, plus the extrapolated point at 0.010 mg/kg, 
should fit with an hyperbolic function after normalizing 
to the y =y/maximum value (Fig. 3). Non-linear fits 
were performed on computed ata by a family of hyper- 
bolic functions following the equation y = A .(x / l  + x ). 
Least-square estimation returns a value of 0.760 for the 
coefficient A and a global fit of 0.238. Because our results 
are fitted acceptably with an hyperbole, it is possible that 
the reduction of PERG response to 4 c/deg stimulation 
is mediated by a specific oupling between the antagonist 
and the D2 receptors. 
The effect observed at l c/deg, already described 
(Stanzione et al., 1992), was more variable in mean 
percentage change and statistically significant only with 
the highest dose (1.428 mg/kg). A grating stimulus with 
a square-wave profile does not contain all its power in 
a single spatial frequency, but also in the odd harmonics 
multiple of the basic frequency (Bodis-Wollner, 
Brannan, Ghilardi & Mylin, 1990). Therefore part of 
the response may be evoked by SFs higher than the 
fundamental (i.e. in our case 3 or 5 c/deg). The observed 
reduction of l c/deg response could, therefore, be 
partially produced by the effect of /-sulpiride on the 
responses evoked by the higher spatial frequencies in 
the square-wave stimulus (i.e. 3 and 5 c/deg). 
These findings suggest hat D2 receptors are mainly 
located on retinal pathways (photoreceptor-bipolar- 
ganglion cell) mediating the response to medium SFs. 
Given the square profile of our stimulus, also odd 
harmonics, multiples of 4 c/deg (i.e. 12 c/deg) contain a 
significant power. Part of our PERG response to 4 c/deg 
stimulation could be produced by these harmonics. 
Human PERG response to SF higher than 10 c/deg is, 
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FIGURE 2. PERG amplitude variations expressed as the mean of the individual percentage variations following the 
administration f the doses of l-sulpiride. Each column represents he variation observed for each dose at each of the used 
SFs: 0,25 c/deg (left), 1 c/deg (middle) and 4 c/deg (right). Asterisks represent the significance l vel of each difference with the 
relative control value calculated by means of planned comparison i the ANOVA: *P < 0.05; **P < 0.01. Bonferroni test has 
been reported as OP < 0.05. 
however, reported to be negligible (Hess & Backer, 
1984). Virtually all of our PERG response to 4 c/deg can 
be considered to be produced by this medium SF, 
although we do not have data concerning possible 
variations at higher SF (i.e. 6--8 c/deg). Medium SF 
responses have been, however, described to be selectively 
altered in PD patients in psychophysical (Bodis-Wollner 
et al., 1987) and by retinal electrophysiological studies 
(Stanzione, PiereUi, Peppe, Stefano, Rizzo, Morocutti & 
Bernardi, 1989). The reported selective impairment of 
PERG responses to 4 c/deg after l-sulpiride adminis- 
tration, suggests that the blockade of D2 receptors 
mimics the PD visual dysfunction. A study on the effects 
of D I selective antagonists would be very interesting. 
120 
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N 8O 
.~ 6O 
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2o 
0 - -  I L I I I I I 
0 0.2 0.4 0.6 0.8 1 1.2 1.4 1.6 
l-Sulpiride dose (mglkg) 
FIGURE 3. Curve fitting of the observed variations of PERG 
responses to4 c/deg, obtained by administering different doses of 
l-sulpiride. The value at 0.010 mg/kg isextrapolated. The global fit was 
0.238. 
Unfortunately, flupentixol, the only clinically available 
drug with D1 antagonist activity, is not reported to 
be highly selective for D1 receptors (Tamminaga &
Gerlach, 1987). Data obtained with such a drug could 
be not conclusive. 
Our stimulator allows to perform 4 c/deg stimulation 
only by positioning the monitor at 2.4 m, thus reducing 
the stimulated retinal area from 11o55 ' to 5°42 ' . This 
reduction of the stimulated area to only the foveal 
region, may be an alternative xplanation for the SF 
selectivity of the dose-dependent effect of l-sulpiride, 
explaining why it was observed only at 4 c/deg. Recent 
data concerning the in situ hybridization of mRNA for 
D2 receptors in the human retina have shown D2 
receptors both in the inner and outer nuclear layers 
(Dearry et al., 1991). Consistently dopamine (DA) fibres 
innervation i  the human retina has been described as 
organized in both the plexiform layers (Frederick et al., 
1982; Stormann, Gdula, Weiner & Brann, 1990), or in 
two plexuses, one internal and the other external, both 
arranged in concentric zones (Savy, Simon & Nguyen- 
Legros, 1992). Some authors, however, did not find DA 
fibres in the outer plexiform layer (Crooks & Kolb, 
1992). Aside from this layer distribution, ot very much 
is known about possible different foveal and extrafoveal 
dopaminergic nnervation in humans. Therefore, with 
the present knowledge, the anatomical data do not 
support or refute a topographic organization of dopa- 
minergic D2 transmission able to selectively effect foveal 
responses. Our electrophysiological d ta seem to suggest 
that a specific action of D2 antagonist is present at least 
in the foveal region which, in our model, was selectively 
activated by the 4 c/deg stimulation. PERG responses 
produced by lower SF, originate mostly from extrafoveal 
regions where ganglion cells with larger receptive field 
are located. With regard to this knowledge, our electro- 
physiological data could be interpreted either as D2 
transmission is located only on the "channels" convey- 
ing medium SF, independently from their location, 
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either as D2 receptors are less present in more eccentric 
retinal area. The effect of  a specific D2 antagonist on 
the responses originating from these areas will be 
expected to be very low, as observed in our study, with 
all the doses of  /-sulpiride on the 0.25 c/deg induced 
responses. 
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